Corrigendum: Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients

Molecular Therapy - United States
doi 10.1038/mt.2013.229
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

Corrigendum: Muscle-Specific CRISPR/Cas9 Dystrophin Gene Editing Ameliorates Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Deficiency of Dystrophin-Associated Proteins in Duchenne Muscular Dystrophy Patients Lacking COOH-terminal Domains of Dystrophin.

Journal of Clinical Investigation
Medicine
1993English

Molecular Characterization of Exonic Rearrangements and Frame Shifts in the Dystrophin Gene in Duchenne Muscular Dystrophy Patients in a Saudi Community

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2018English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

BMC Medical Genomics
Genetics
2011English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy